Methylation assay by nucleotide incorporation: a quantitative assay for regional CpG methylation density.
Although the aberrant methylation in CpG islands is of great interest as a causative role in human malignancies, it has been very difficult to accurately determine methylation density. Here we report a novel microplate-based quantitative methylation assay, designated MANIC, for a region containing a number of CpG sites based on incorporation of hapten-labeled dCTP at cytosine sites where the methylated cytosines have not been converted to uracil by the bisulfite treatment. Validation using control DNAs revealed that the method was sensitive enough to detect < 1.25% methylated DNA and that calibration curve was linear. With this approach, we determined relative methylation density of O6-methylguanine-DNA methyltransferase gene promoter containing 12 CpG sites among the 12 colorectal cancers and corresponding normal mucosal tissues. Consequently, MANIC showed a high concordance with results by a quantitative method, bisulfite PCR single-stranded conformational polymorphism (BiPS). MANIC is a technique that avoids cumbersome procedures such as electrophoresis or the use of radiolabeling and is applicable to any sequence regardless of the total number of CpG sites or heterogeneity in methylation status.
Yamamoto
Takeshi
T
International Reagents Corporation, Sysmex Corporation, Kobe, Japan.
Nagasaka
Takeshi
T
Notohara
Kenji
K
Sasamoto
Hiromi
H
Murakami
Jun
J
Tanaka
Noriaki
N
Matsubara
Nagahide
N
D002874:Chromosome Mapping / Q000379:methods*; D015179:Colorectal Neoplasms / Q000235:genetics*; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D009711:Nucleotides / Q000235:genetics*; D017422:Sequence Analysis, DNA / Q000379:methods*; D014407:Tumor Cells, Cultured
D009711:Nucleotides